Concepedia
1
Publications
15
Citations
H-Index
2022
Active since
Affiliations
Zhengzhou University(Current)
Weizhen Fang is an author at Zhengzhou University.
Publications per year
2022–2022
320MO Envonalkib vs crizotinib in treatment-naïve advanced ALK-positive NSCLC: A randomized, multicenter, phase III trial
L. Zhang, Weizhen Fang, J. Min et al. · Annals of Oncology · 2022 · 15 citations
Rows per page
1–1 of 1